Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRevel Collect Regulatory News (RBG)

  • There is currently no data for RBG

Share Options

24 Oct 2019 07:00

RNS Number : 9399Q
Revolution Bars Group
24 October 2019
 

Revolution Bars Group plc

("Revolution" or the "Company")

Grant of awards under the Revolution Bars Group Plc Performance Share Plan (the "Plan)

The Company announces that on 23 October 2019, it granted options under the Plan with an exercise price of £0.001 per share over, in aggregate, 916,269 ordinary shares of £0.001 each in the Company ("Ordinary Shares") (the "PSP Options") to directors and other persons discharging managerial responsibility ("PDMRs") as set out in the table below.

The PSP Options shall vest and become exercisable on the date the Remuneration Committee determines that the performance targets set out below have been met, which is likely to be on the date that is the later of the preliminary announcement of the results for the year ended June 2022 and 23 October 2022.

Name

Position

Number of Ordinary Shares under PSP Option

Rob Pitcher

CEO

531,269

Kate Eastwood

Sales and Marketing Director

50,000

Mark Walter

Operations Director Revolution South

50,000

Alex Stanhope

Property Director

50,000

Beth Anderson

Head of People

25,000

Myles Doran

Commercial Director

50,000

Andy Dyson

Operations Director Revolution North

50,000

Clinton Ghent

Operations Director Revolucion de Cuba

50,000

The award to Rob Pitcher relates to the commitment given in his offer letter and equates to 100% salary based on the average mid-market share price in the five days prior to issue.

The performance targets relating to the PSP Options have been amended following feedback from a number of investors. They are as follows:

(i) 70% of the award is based on Earnings per Share (EPS) growth. An EPS of 7 pence per share for the year to 30 June 2022 will provide for 25% of this part of an award vesting, increasing pro rata to 100% of this part of the award vesting at 11.5 pence. These EPS targets equate to annualised growth rates of c27% per annum and 50% per annum compared to the original 7% per annum and 13% per annum targets set out in the Directors' Remuneration Report for the year ended June 2019; and

(ii) 30% of the awards are based on Total Shareholder Return - no changes have been made to this element of the award as set out in the Directors' Remuneration Report for the year ended June 2019.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHPGGBAUUPBPUW
Date   Source Headline
22nd Jun 20218:50 amRNSDirector/PDMR Shareholding
18th Jun 20218:06 amRNSHolding(s) in Company
15th Jun 20214:23 pmRNSDirector/PDMR Shareholding
15th Jun 20218:27 amRNSSchedule 2(g) Update
14th Jun 20212:31 pmRNSResult of GM, Director/PDMR, Total Voting Rights
14th Jun 20217:00 amRNSResult of Open Offer
27th May 20216:11 pmRNSPublication and Despatch of Circular
26th May 20217:00 amRNSResults of the Firm Placing and Placing
25th May 20214:44 pmRNSFirm Placing and Placing and Open Offer
19th May 20211:04 pmRNSHolding(s) in Company
11th May 20217:00 amRNSRe-opening Update
13th Apr 20217:00 amRNSInterim Results
4th Mar 20217:00 amRNSCOVID-19 Update/Notification Interim Results Date
15th Feb 202112:01 pmRNSResult of General Meeting
22nd Jan 20211:07 pmRNSNotice of GM
4th Jan 20214:41 pmRNSSecond Price Monitoring Extn
4th Jan 20214:35 pmRNSPrice Monitoring Extension
24th Dec 202011:36 amRNSGrant of Options
22nd Dec 202012:30 pmRNSResult of AGM
21st Dec 20209:05 amRNSSecond Price Monitoring Extn
21st Dec 20209:00 amRNSPrice Monitoring Extension
17th Dec 20207:00 amRNSPreliminary Results
10th Dec 20204:41 pmRNSSecond Price Monitoring Extn
10th Dec 20204:36 pmRNSPrice Monitoring Extension
27th Nov 20203:40 pmRNSNotice of 2020 Annual General Meeting
17th Nov 202011:40 amRNSHolding(s) in Company
16th Nov 20202:06 pmRNSSecond Price Monitoring Extn
16th Nov 20202:00 pmRNSPrice Monitoring Extension
13th Nov 20202:37 pmRNSCVA successfully approved
9th Nov 20204:41 pmRNSSecond Price Monitoring Extn
9th Nov 20204:37 pmRNSPrice Monitoring Extension
9th Nov 20202:06 pmRNSSecond Price Monitoring Extn
9th Nov 20202:00 pmRNSPrice Monitoring Extension
28th Oct 20205:12 pmRNSHolding(s) in Company
28th Oct 20208:48 amRNSHolding(s) in Company
28th Oct 20208:41 amRNSHolding(s) in Company
27th Oct 20207:00 amRNSLaunch of CVA in subsidiary entity
12th Oct 202012:16 pmRNSHolding(s) in Company
6th Oct 20204:40 pmRNSHolding(s) in Company
1st Oct 20203:36 pmRNSHolding(s) in Company
28th Sep 202012:59 pmRNSHolding(s) in Company
25th Sep 20202:05 pmRNSSecond Price Monitoring Extn
25th Sep 20202:01 pmRNSPrice Monitoring Extension
25th Sep 202011:26 amRNSStatement re press speculation
18th Sep 20201:25 pmRNSHolding(s) in Company
9th Sep 20205:02 pmRNSHolding(s) in Company
8th Sep 202010:15 amRNSHolding(s) in Company
3rd Sep 20207:00 amRNSTrading Update and FY results reporting date
21st Aug 202010:58 amRNSHolding(s) in Company
31st Jul 20202:35 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.